Can maternal serum soluble fms‐like tyrosine kinase‐1 to placental growth factor levels at term anticipate adverse pregnancy outcomes?

Documenti analoghi

• Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: A retrospective cohort study
  di: Rebecca L. Zur, et al.
  Pubblicazione: (2024)
• External validation of a risk‐scoring model for predicting adverse perinatal outcomes in pregnancies with fetal growth restriction
  di: Jiratchaya Lekhalawan, et al.
  Pubblicazione: (2025)
• Placental biomarkers in the first trimester and adverse pregnancy outcome
  di: Maryam Amjad
  Pubblicazione: (2024)
• Diagnostic and prognostic values of serum insulin‐like growth factor binding protein 4 expression in cervical cancer
  di: Mingyang Wang, et al.
  Pubblicazione: (2025)
• Elevated levels of apolipoprotein A4 in umbilical cord serum from the maternal major depressive disorder
  di: Seiko Matsuo, et al.
  Pubblicazione: (2024)